• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤学中的潜在治疗靶点:蛋白质棕榈酰化(综述)

Potential therapeutic target in oncology: Protein palmitoylation (Review).

作者信息

Hao Shiping, Mei Yongming, Chen Shaolin, Liu Jing, Zhang Yao, Zhu Zhengfeng, Zuo Kangjia

机构信息

The Public Experimental Center of Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.

Department of Nursing, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.

出版信息

Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8950. Epub 2025 Jul 19.

DOI:10.3892/or.2025.8950
PMID:40682839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308834/
Abstract

Post‑translational modifications (PTMs) of proteins, by altering the structural conformation of precursor polypeptides, play an indispensable role in augmenting the diversity and stability of the proteome. PTMs exert profound influence on various hallmarks of tumor biology, including cellular proliferation, apoptosis, angiogenesis and metastatic dissemination. Accordingly, advancing our understanding of PTMs holds substantial promise for broadening the therapeutic landscape of oncology. Among these modifications, palmitoylation, a reversible lipid‑based PTM, critically modulates protein stability, membrane localization, protein‑protein interactions and signal transduction cascades. Dysregulation of palmitoylation has been increasingly implicated in tumorigenesis, suggesting its aberrant forms as putative targets for therapeutic intervention. The present review delineates the biochemical mechanisms underlying protein palmitoylation and synthesizes current insights into its multifaceted roles in tumor progression, immune modulation and metabolic regulation, thereby offering novel perspectives for the development of targeted cancer therapies.

摘要

蛋白质的翻译后修饰(PTMs)通过改变前体多肽的结构构象,在增加蛋白质组的多样性和稳定性方面发挥着不可或缺的作用。PTMs对肿瘤生物学的各种特征产生深远影响,包括细胞增殖、凋亡、血管生成和转移扩散。因此,加深我们对PTMs的理解对于拓宽肿瘤学治疗前景具有重大意义。在这些修饰中,棕榈酰化是一种可逆的基于脂质的PTM,它对蛋白质稳定性、膜定位、蛋白质-蛋白质相互作用和信号转导级联反应起着关键的调节作用。棕榈酰化失调越来越多地与肿瘤发生相关,这表明其异常形式可作为治疗干预的潜在靶点。本综述阐述了蛋白质棕榈酰化的生化机制,并综合了目前对其在肿瘤进展、免疫调节和代谢调节中的多方面作用的见解,从而为开发靶向癌症治疗提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a6/12308834/6434851c105e/or-54-04-08950-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a6/12308834/1234864dfebe/or-54-04-08950-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a6/12308834/6434851c105e/or-54-04-08950-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a6/12308834/1234864dfebe/or-54-04-08950-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a6/12308834/6434851c105e/or-54-04-08950-g01.jpg

相似文献

1
Potential therapeutic target in oncology: Protein palmitoylation (Review).肿瘤学中的潜在治疗靶点:蛋白质棕榈酰化(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8950. Epub 2025 Jul 19.
2
The shadow of cancer therapeutic resistance: Unveiling the role of S-palmitoylation.癌症治疗耐药性的阴影:揭示S-棕榈酰化的作用
Drug Resist Updat. 2025 Sep;82:101264. doi: 10.1016/j.drup.2025.101264. Epub 2025 Jun 2.
3
Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike protein by antagonizing its degradation via chaperone-mediated autophagy to facilitate viral proliferation.棕榈酰化通过拮抗伴侣介导的自噬对猪流行性腹泻病毒刺突蛋白的降解来增强其稳定性,从而促进病毒增殖。
J Virol. 2025 Jun 17;99(6):e0034725. doi: 10.1128/jvi.00347-25. Epub 2025 May 22.
4
Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson's disease: a narrative review.棕榈酰化修饰介导的蛋白质调控网络在帕金森病病理进展中的作用:一篇叙述性综述
Front Immunol. 2025 Jul 9;16:1615001. doi: 10.3389/fimmu.2025.1615001. eCollection 2025.
5
Targeting post-translational modifications: novel insights into bone metabolic diseases.靶向翻译后修饰:对骨代谢疾病的新见解。
J Adv Res. 2025 Jun 13. doi: 10.1016/j.jare.2025.06.020.
6
YAP as a therapeutic target in esophageal squamous cell carcinoma: insights and strategies.YAP作为食管鳞状细胞癌的治疗靶点:见解与策略
Ann Med. 2025 Dec;57(1):2536200. doi: 10.1080/07853890.2025.2536200. Epub 2025 Jul 22.
7
A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer.H3K27ac中表观遗传标记的叙述性综述及其作为癌症治疗靶点的新潜力。
Epigenomics. 2025 Mar;17(4):263-279. doi: 10.1080/17501911.2025.2460900. Epub 2025 Feb 21.
8
Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.油橄榄苦素作为一种多功能抗癌剂:作用机制见解、先进递送策略及精准肿瘤学中的协同作用
Int J Mol Sci. 2025 Jun 9;26(12):5521. doi: 10.3390/ijms26125521.
9
DNAJA: emerging targets for anti-tumor therapy.DNAJA:抗肿瘤治疗的新兴靶点。
Future Oncol. 2025 Jul;21(17):2251-2259. doi: 10.1080/14796694.2025.2514417. Epub 2025 Jun 3.
10
Lenvatinib promotes hepatocellular carcinoma pyroptosis by regulating GSDME palmitoylation.乐伐替尼通过调节GSDME的棕榈酰化促进肝细胞癌焦亡。
Cancer Biol Ther. 2025 Dec;26(1):2532217. doi: 10.1080/15384047.2025.2532217. Epub 2025 Jul 13.

本文引用的文献

1
Posttranslational remodeling micelle reverses cell-surface and exosomal PD-L1 immunosuppression in tumors resistant to PD-L1 antibody therapy.翻译后修饰重塑胶束可逆转对PD-L1抗体治疗耐药的肿瘤中的细胞表面和外泌体PD-L1免疫抑制作用。
J Control Release. 2025 Aug 10;384:113961. doi: 10.1016/j.jconrel.2025.113961. Epub 2025 Jun 14.
2
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy.VDAC2缺失引发肿瘤破坏和炎症以用于癌症治疗。
Nature. 2025 Apr;640(8060):1062-1071. doi: 10.1038/s41586-025-08732-6. Epub 2025 Mar 19.
3
Palmitoylation of PD-L1 Regulates Its Membrane Orientation and Immune Evasion.
PD-L1的棕榈酰化修饰调控其膜定位及免疫逃逸。
Langmuir. 2025 Mar 4;41(8):5170-5178. doi: 10.1021/acs.langmuir.4c04441. Epub 2025 Feb 18.
4
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies.胃癌免疫治疗的进展:揭示免疫检查点抑制剂的潜力及新兴策略
Biochim Biophys Acta Rev Cancer. 2025 Apr;1880(2):189277. doi: 10.1016/j.bbcan.2025.189277. Epub 2025 Feb 10.
5
ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation.ZDHHC18通过调节HRAS棕榈酰化促进肾纤维化发展。
J Clin Invest. 2025 Feb 4;135(6):e180242. doi: 10.1172/JCI180242.
6
Targeting ion channels: innovative approaches to combat cancer drug resistance.靶向离子通道:对抗癌症耐药性的创新方法。
Theranostics. 2025 Jan 1;15(2):521-545. doi: 10.7150/thno.103384. eCollection 2025.
7
ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis.ZDHHC20介导的脂肪酸合酶(FASN)的S-棕榈酰化促进肝癌发生。
Mol Cancer. 2024 Dec 19;23(1):274. doi: 10.1186/s12943-024-02195-5.
8
Theoretical framework and emerging challenges of lipid metabolism in cancer.癌症中脂质代谢的理论框架与新出现的挑战
Semin Cancer Biol. 2025 Jan;108:48-70. doi: 10.1016/j.semcancer.2024.12.002. Epub 2024 Dec 12.
9
Palmitic Acid Accelerates Endothelial Cell Injury and Cardiovascular Dysfunction via Palmitoylation of PKM2.棕榈酸通过丙酮酸激酶M2的棕榈酰化加速内皮细胞损伤和心血管功能障碍。
Adv Sci (Weinh). 2025 Feb;12(5):e2412895. doi: 10.1002/advs.202412895. Epub 2024 Dec 12.
10
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events.免疫检查点抑制剂与肝脏:权衡治疗益处与不良事件
Gut. 2025 Jun 6;74(7):1165-1177. doi: 10.1136/gutjnl-2024-332125.